The product was manufactured by Lupin Ltd at its Pithampur facility in Madhya Pradesh. The voluntary ongoing nationwide recall is a class I...

The move is aimed at allowing women to protect their reproductive rights.

Glenmark Pharmaceuticals has received final approval from the US health regulator USFDA for oral contraceptives and leukemia treatment inje...

The S&P BSE Sensex surged over 100 points in early morning trade on Thursday, led by gains in RIL, Infosys, ICICI Bank, L&T, TCS, and SBI.

The Indian market is expected to trade in a range. Here is a list of top fourteen stocks that are likely to be in focus today.

The product has an estimated market size of $64 million for the twelve months ending October 2015 according to IMS, Aurobindo Pharma said.

The approval marks the company's 12th oral contraceptive and 2nd extended-cycle oral contraceptive authorised for distribution by the USFDA.

The FDA had initially decided to approve over-the-counter sales with no age limits, but Sebelius ordered it to reverse course.

Indian shares are expected to trade in a range. Here is a list of fifteen stocks that are likely to be in action in morning trade today.

Lupin said that it has received final approval from the US health regulator to sell its generic oral contraceptive Levonorgestrel and Ethin...

Drug firm Lupin today said it has received final approval from the US health regulator to market its generic Levonorgestrel and Ethinyl Est...

Drug firm Lupin today said its subsidiary has received American health regulator's approval to market its generic oral contraceptive tablet...

The country's second-largest pharmaceuticals company, Cipla, is in talks with an international health group to expand its contraceptive pil...

Lupin has received approval from USFDA to sell 'LoSeasonique' tablets, an oral contraceptive drug, in the American mkt.